BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24225965)

  • 1. Joint statement by members of the NCCN Prostate Cancer Guidelines Panel.
    Mohler JL;
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1310-2. PubMed ID: 24225965
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer: IMRT treatment rates increase with urologist self-referral.
    Phillips R
    Nat Rev Urol; 2013 Dec; 10(12):680. PubMed ID: 24217677
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensity-modulated radiation therapy for prostate cancer.
    Jacobs BL; Schroeck FR; Hollenbeck BK
    N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521127
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy for prostate cancer.
    Sartor O; Silberstein JL
    N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521126
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2014 Feb; 370(7):679-80. PubMed ID: 24521125
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Penson DF
    J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
    [No Abstract]   [Full Text] [Related]  

  • 7. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US urology clinics overprescribe prostate radiotherapy.
    Furlow B
    Lancet Oncol; 2011 Feb; 12(2):122. PubMed ID: 21355130
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare fee reductions and the overuse of intensity-modulated radiotherapy.
    Howard DH; Hockenberry J
    Health Serv Res; 2021 Aug; 56(4):626-634. PubMed ID: 33905136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhering to the standard of care for prostate cancer.
    Kapoor DA; Penson D
    Health Aff (Millwood); 2012 Jun; 31(6):1367; author reply 1367. PubMed ID: 22665854
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
    Zimberg SH; Olsson CA
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1607; author reply 1607-8. PubMed ID: 21092840
    [No Abstract]   [Full Text] [Related]  

  • 12. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
    Schilling PJ
    Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in urology standard of care.
    Plandowski JW
    Health Aff (Millwood); 2012 Jun; 31(6):1367; author reply 1367. PubMed ID: 22665853
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
    Falit BP; Gross CP; Roberts KB
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
    [No Abstract]   [Full Text] [Related]  

  • 15. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.
    Mitchell JM
    Health Aff (Millwood); 2012 Apr; 31(4):741-9. PubMed ID: 22492891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-referral in radiation oncology: has caveat emptor replaced primum non nocere?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):874. PubMed ID: 23078893
    [No Abstract]   [Full Text] [Related]  

  • 17. Profit and questions as doctors offer prostate cancer therapy.
    Saul S
    N Y Times Web; 2006 Dec; ():A1, C7. PubMed ID: 17167872
    [No Abstract]   [Full Text] [Related]  

  • 18. In regard to Anscher.
    Brezovich IA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1156. PubMed ID: 23517804
    [No Abstract]   [Full Text] [Related]  

  • 19. The organization and economics of prostate seed implantation programs.
    Wodinsky HB; Porter A; Silverstein M; Pontes E
    J Oncol Manag; 1998; 7(3):16-20. PubMed ID: 10181576
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.